Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

The major challenge in prostate cancer screening is not just to find more cancer cases, but to identify the cancers that are ...

A next-generation Stockholm3 blood test detected aggressive prostate cancer more accurately than PSA, improving early ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

State-funded clinical study will validate the OTraces’ proteomic blood test ability to reduce unnecessary prostate biopsies in men with elevated PSADEERFIELD BEACH, Fla., June 25, 2026 (GLOBE NEWSWIRE ...

Millions of men face a decision about whether to be screened for prostate cancer. National guidelines say that decision ...

Key Takeaways The Stockholm3 blood test detects more prostate cancers than the standard PSA testThe test detects more ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...